Trial Profile
Efficacy of Bimagrumab in terms of improvement in body composition and insulin sensitivity in insulin resistant population
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Aug 2018
Price :
$35
*
At a glance
- Drugs Bimagrumab (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 Jul 2017 New trial record
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association